Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
PUT
Live Nation Entertainment
LYV
$43.9B
| $33.4M | 0.01% |
404,700
+5,900
| +1% | +$568K |
|
1327
Alcon
ALC
$36.1B
| $33.4M | 0.01% |
477,718
+471,265
| +7,303% | +$34.4M |
|
1328
Campbell Soup
CPB
$6.94B
| $33.4M | 0.01% |
694,475
+579,994
| +507% | +$27.3M |
|
1329
Sprouts Farmers Market
SFM
$7.75B
| $33.4M | 0.01% |
1,317,308
+177,794
| +16% | +$4.94M |
|
|
UNIT
1330
Uniti Group
UNIT
$2.42B
| $33.3M | 0.01% |
3,538,657
+898,354
| +34% | +$10.4M |
|
1331
PUT
Zebra Technologies
ZBRA
$17.7B
| $33.3M | 0.01% |
113,400
+57,300
| +102% | +$20M |
|
1332
CALL
Doximity
DOCS
$4.46B
| $33.3M | 0.01% |
957,200
+542,700
| +131% | +$21.4M |
|
|
1333
CALL
Zebra Technologies
ZBRA
$17.7B
| $33.3M | 0.01% |
113,300
+17,900
| +19% | +$6.23M |
|
1334
CALL
Ross Stores
ROST
$78.8B
| $33.3M | 0.01% |
474,200
+192,100
| +68% | +$17.1M |
|
1335
Syndax Pharmaceuticals
SNDX
$1.7B
| $33.3M | 0.01% |
1,729,052
-96,388
| -5% | -$1.61M |
|
1336
CALL
W.W. Grainger
GWW
$62.4B
| $33.3M | 0.01% |
73,200
+39,000
| +114% | +$19M |
|
1337
CALL
Stanley Black & Decker
SWK
$15.3B
| $33.3M | 0.01% |
317,100
-69,100
| -18% | -$8.5M |
|
|
COHR
1338
DELISTED
Coherent Inc
COHR
| $33.2M | 0.01% |
124,693
+27,053
| +28% | +$7.25M |
|
1339
JFrog
FROG
$11.8B
| $33.1M | 0.01% |
1,572,573
-377,575
| -19% | -$7.92M |
|
1340
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.96B
| $33.1M | 0.01% |
894,746
+661,471
| +284% | +$26.9M |
|
1341
PUT
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$23.9B
| $33M | 0.01% |
2,521,600
+856,500
| +51% | +$19.3M |
|
1342
CALL
Monolithic Power Systems
MPWR
$67.7B
| $33M | 0.01% |
85,900
+45,100
| +111% | +$19.1M |
|
1343
iShares Core MSCI Emerging Markets ETF
IEMG
$158B
| $33M | 0.01% |
672,272
-7,073,580
| -91% | -$366M |
|
1344
CALL
Coherent
COHR
$63.1B
| $32.9M | 0.01% |
645,400
+276,500
| +75% | +$16.9M |
|
1345
PUT
Nasdaq
NDAQ
$54.2B
| $32.8M | 0.01% |
645,600
+109,800
| +20% | +$5.81M |
|
1346
Aura Biosciences
AURA
$788M
| $32.8M | 0.01% |
2,312,159
-4,494
| -0.2% | -$74.4K |
|
1347
Jabil
JBL
$38.1B
| $32.7M | 0.01% |
638,650
+513,981
| +412% | +$29.8M |
|
1348
HealthEquity
HQY
$8.86B
| $32.6M | 0.01% |
531,807
+249,993
| +89% | +$16M |
|
1349
Logitech
LOGI
$14.8B
| $32.6M | 0.01% |
626,993
+519,219
| +482% | +$32M |
|
|
SGEN
1350
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
| $32.6M | 0.01% |
184,400
+152,300
| +474% | +$21.9M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.